Moclavin (Amoxicillin, Potassium Clavulanate)

Amoxicillin and potassium clavulanate, the active ingredient in Moclavin, is a penicillin beta‑lactam antibiotic presented as an oral tablet formulation for oral use. It treats a broad range of bacterial infections in adults and children when prescribed by a qualified health professional.

GNH USA supplies Moclavin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moclavin, a beta‑lactam antibacterial, is employed to manage infections caused by susceptible bacteria across several organ systems. - Acute otitis media: eradicates the causative pathogens and relieves ear pain. - Community‑acquired pneumonia: clears pulmonary infection and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and restores normal drainage. - Skin and soft‑tissue infections: eliminates skin‑resident bacteria and promotes wound healing. - Urinary tract infection: clears urinary pathogens and resolves dysuria.

Adverse reactions may occur with any antibiotic therapy and should be monitored.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: loose stools, often self‑limiting. - Vomiting: occasional emesis. - Abdominal pain: cramping or discomfort. - Rash: non‑specific skin eruption. - Headache: transient mild pain.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with airway compromise. - Clostridioides difficile‑associated colitis: severe diarrhea with possible colitis. - Hepatic enzyme elevation: transient increase in liver transaminases. - Stevens‑Johnson syndrome: severe mucocutaneous blistering. - Neutropenia: marked reduction in white blood cells. - Seizures: rare neurotoxic events, especially in renal impairment.

Use of Moclavin requires careful assessment of patient history and clinical status. - Allergy assessment: avoid in individuals with known penicillin hypersensitivity. - Renal function: dose adjustment may be needed in severe renal impairment. - Hepatic disease: monitor liver function tests during therapy. - Concomitant antibiotics: avoid simultaneous use with bacteriostatic agents unless clinically justified. - Pregnancy and lactation: prescribe only when benefit outweighs potential risk. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Moclavin may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Allopurinol: increased risk of severe skin reactions. - Methotrexate: heightened toxicity due to reduced clearance. - Warfarin: possible enhancement of anticoagulant effect.

Moderate Interactions (Monitor Closely): - Antacids containing aluminum or magnesium: may reduce oral absorption. - Oral contraceptives: potential reduction in hormonal efficacy.